Research Grant Guidelines
The A-T Children's Project accepts grant applications March 1st and September 1st of each calendar year for up to US$75,000.00 per year for two years.
Find more information on special awards for postdocs who decide to pursue research with the potential to find life-improving therapies for A-T.
Find a list of some of the research grants funded since the A-T Children's Project's inception in 1993.
Building on Advancements to Reach a Cure
The A-T Children's Project provides competitive awards for basic science, translational and clinical research grants related to ataxia-telangiectasia. One and two-year projects are funded up to a maximum total direct cost of $75,000 per year. No administrative overhead or fixed costs are supported.
In giving these grant awards, the Project strives to assist respected scientists in developing a clearer understanding of ataxia-telangiectasia. We are determined to find a timely cure, or life-improving treatments, for this serious disease.
Scientific excellence and relevance to A-T are the paramount criteria used to select supported research projects. Junior investigators, scientists in related disciplines, and individuals with innovative new ideas for A-T research are particularly encouraged to apply for grants, as are laboratories and teams working together from industry as well as teaching universities. Grant award decisions are made through a careful and detailed, two-tiered, peer-review selection process. Grants are reviewed and awarded relatively rapidly so that we are usually able to provide a grant decision within 90 days after receiving a complete proposal from an investigator.
Consistent with the urgency felt by all families impacted by this disease, the A-TCP's current focus is on funding innovative research strategies that look at A-T in new ways and that include a clear "yes" or "no" answer to the hypotheses rather than merely defining a mechanism. Highest priority is given to projects that, while drawing on basic discoveries, include creative strategies for suggesting and evaluating specific disease-modifying and symptomatic interventions.